Elevance Health
1,706 hedge funds and large institutions have $113B invested in Elevance Health in 2024 Q2 according to their latest regulatory filings, with 148 funds opening new positions, 711 increasing their positions, 548 reducing their positions, and 87 closing their positions.
70% more first-time investments, than exits
New positions opened: 148 | Existing positions closed: 87
30% more repeat investments, than reductions
Existing positions increased: 711 | Existing positions reduced: 548
4% more funds holding in top 10
Funds holding in top 10: 52 → 54 (+2)
2% more funds holding
Funds holding: 1,667 → 1,706 (+39)
5% more capital invested
Capital invested by funds: $107B → $113B (+$5.23B)
0.36% more ownership
Funds ownership: 89.15% → 89.51% (+0.36%)
1% less call options, than puts
Call options by funds: $680M | Put options by funds: $688M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$367M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$277M |
| 3 |
UBS AM
Chicago,
Illinois
|
+$239M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$205M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
+$186M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$202M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$172M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
-$129M |
| 4 |
DCP
D1 Capital Partners
New York
|
-$124M |
| 5 |
BlackRock
New York
|
-$114M |
ELV Hedge Fund Activity: Q2 2024 in Review
1,706 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q2 2024, worth a combined $113B — up 4.9% from $107B a quarter earlier.
Buyers outnumbered sellers: 148 funds opened new ELV positions and 87 closed out — a net gain of 61 holders — while 711 added to existing stakes and 548 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $367M. The largest seller was Qube Research & Technologies (QRT), cutting an estimated $202M.
- 1,706 institutional investors held Elevance Health (ELV) as of Q2 2024, up from 1,667 in Q1 2024.
- Funds reported $113B of Elevance Health stock for Q2 2024, up 4.9% quarter-over-quarter.
- 148 funds opened new Elevance Health positions in Q2 2024 and 87 closed out, a net change of +61 holders.
- The largest Elevance Health buyer in Q2 2024 was Fidelity Investments, an estimated $367M added.
- The largest Elevance Health seller in Q2 2024 was Qube Research & Technologies (QRT), an estimated $202M sold.
Based on aggregated 13F filings for Q2 2024.